USPTO serial 88289737
DONESENS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCMORROW, JANICE LEE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DONESENS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Suresnes Cedex, FR
Suresnes Cedex, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Lederhouse
Rebecca Lederhouse BAKER & MCKENZIE LLP300 EAST RANDOLPH STREET, SUITE 5000CHICAGO, IL 60601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Apparatus and equipment for processing data and information, namely, apparatus for recording, transmission, processing and reproduction of sound, images or data; Apparatus and equipment for processing data and information, namely, computer hardware and recorded and downloadable software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Downloadable and/or recorded Computer programs for providing information on health and wellness, for entering new medical patient data into a database containing pre-recorded medical patient data, for managing and analyzing medical patient data within the database, for users to track their symptoms and record their treatments, for users to track physical activity and vital signs, for accessing and aggregating immunization data for use by health care providers, for tracking, recording and sharing healthcare information; Downloadable and/or recorded Computer software for analyzing, storing and monitoring of physiological data, including diagnostic, monitoring and warning tools; Personal digital assistants; Downloadable and/or recorded Data analysis software for use by health care providers to customize treatments based on patient profiles; Downloadable mobile software application for medical professionals and patients featuring information and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions; Downloadable and/or recorded Artificial intelligence software for healthcare; Downloadable and/or recorded Artificial intelligence software for analysis | ACTIVE | — |
| 010 | Medical diagnostic instruments for diagnosis relating to oncology; Medical device for detecting cancer; Medical device for treating cancer | ACTIVE | — |
| 035 | Business services provided to the healthcare industry, namely, the Collection and compilation of healthcare quality data for business purposes; Updating, processing and maintenance of data in computer databases; Business advice and consultancy relating to financing business data analytics; Systemization of information into computer databases; Compilation of statistics; Business research and data analysis services in the field of genomics, medicine and life sciences; Business research and data analysis services in the field of cancer research, diagnostics, disease classification and personalized medicine; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals, and life sciences; all the aforesaid being provided in relation with the medical and pharmaceutical field | ACTIVE | — |
| 044 | Medical services; Providing medical testing services for diagnostic or treatment purposes and information in the field of personalized medicine; Advisory services relating to health; Pharmaceutical advice; Telemedicine services; Medical diagnostic testing, monitoring and reporting services; Medical reporting services, namely, compilation of medical reports; health consultancy and health counseling; health screening services in the fields of human physiology, activity, sleep, sleep apnea, cardiovascular health, dermatology, hearing, neurology, cancer, endocrinology, hormone and metabolic health; Medical diagnosis and treatment of cancer; medical evaluation of cancer, molecular tumor profiles, biological data and genetic information for the purposes of determining the most promising personalized treatment options | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOFARMA
- Other trademarks owned by BIOFARMA
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named DONESENS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 17, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 17, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 18, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 17, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Feb 17, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 10, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Feb 10, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 31, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 27, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 27, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 27, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 13, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 11, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 11, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 11, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 27, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 25, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 25, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 25, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 5, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 3, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 3, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 3, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 10, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 16, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 10, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 28, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 25, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 24, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 24, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 8, 2019 | NWAP | NEW APPLICATION ENTERED | — |